within Pharmacolibrary.Drugs.ATC.A;

model A07EA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 2e-06,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A07EA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Betamethasone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive effects. It is primarily used for the treatment of various inflammatory and autoimmune conditions, and is also used in the management of adrenal insufficiency. The A07EA04 ATC code refers specifically to its use as an intestinal anti-inflammatory/anti-infective agent. Betamethasone is approved for clinical use and is available in various formulations including oral, intravenous, intramuscular, and topical.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated for healthy adults with oral administration, as no publication with direct PK parameters for betamethasone intestinal use (A07EA04) could be identified.</p><h4>References</h4><ol><li><p>Jobe, AH, Milad, MA, Peppard, T, &amp; Jusko, WJ (2020). Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. <i>Clinical and translational science</i> 13(2) 391–399. DOI:<a href=\"https://doi.org/10.1111/cts.12724\">10.1111/cts.12724</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31808984/\">https://pubmed.ncbi.nlm.nih.gov/31808984</a></p></li><li><p>Schmidt, AF, Jobe, AH, Kannan, PS, Bridges, JP, Newnham, JP, Saito, M, Usuda, H, Kumagai, Y, Fee, EL, Clarke, M, &amp; Kemp, MW (2019). Oral antenatal corticosteroids evaluated in fetal sheep. <i>Pediatric research</i> 86(5) 589–594. DOI:<a href=\"https://doi.org/10.1038/s41390-019-0519-0\">10.1038/s41390-019-0519-0</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31365919/\">https://pubmed.ncbi.nlm.nih.gov/31365919</a></p></li><li><p>Krzyzanski, W, Milad, MA, Jobe, AH, Peppard, T, Bies, RR, &amp; Jusko, WJ (2021). Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women. <i>Journal of pharmacokinetics and pharmacodynamics</i> 48(2) 261–272. DOI:<a href=\"https://doi.org/10.1007/s10928-020-09730-z\">10.1007/s10928-020-09730-z</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33389521/\">https://pubmed.ncbi.nlm.nih.gov/33389521</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A07EA04;
